UBS AM’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.07M | Sell |
|
|||||
|
2025
Q2 | $2.4M | Buy |
|
|||||
|
2025
Q1 | $2.47M | Buy |
|
|||||
|
2024
Q4 | $2.25M | Buy |
|
|||||
|
2024
Q3 | $2.65M | Sell |
|
|||||
|
2024
Q2 | $3.15M | Buy |
|
|||||
|
2024
Q1 | $2.3M | Buy |
|
|||||
|
2023
Q4 | $2.01M | Buy |
|
|||||
|
2023
Q3 | $1.11M | Buy |
|
|||||
|
2023
Q2 | $1.13M | Hold |
|
|||||
|
2023
Q1 | $1.13M | Sell |
|
|||||
|
2022
Q4 | $1.48M | Buy |
|
|||||
|
2022
Q3 | $1.04M | Sell |
|
|||||
|
2022
Q2 | $890K | Buy |
|
|||||
|
2022
Q1 | $676K | Hold |
|
|||||
|
2021
Q4 | $851K | Hold |
|
|||||
|
2021
Q3 | $743K | Sell |
|
|||||
|
2021
Q2 | $733K | Buy |
|
|||||
|
2021
Q1 | $858K | Buy |
|
|||||
|
2020
Q4 | $583K | Buy |
|